GH1 and pulmonary arterial hypertension: The height standard deviation score (SDS), height velocity, and predicted adult height (PAH) of the patients with PGHD, CGHD, and SGA values were significantly higher than ISS patients at the end of the third year of a similar dose of GH treatment.